OCT 19, 2021 5:00 PM PDT

Researchers develop a potent antiviral drug for dengue fever

WRITTEN BY: J. Bryce Ortiz

Dengue fever is a mosquito borne illness that is widespread, especially in tropical countries. The global incidence of dengue fever has increased dramatically over the past decade with current estimates reporting that, worldwide, there are 390 million dengue fever infections each year. Of these infections, 96 million individuals show clinical symptoms, and the number of deaths hovers around 5000 per year. Because of this, in 2019, the World Health Organization included dengue fever in its list of top ten threats to global health. The symptoms of dengue fever include high fever, severe headache, pain behind the eyes, muscle and joint pains, and nausea and vomiting. If symptoms persist, dengue can become fatal from fluid accumulation, respiratory distress, severe bleeding, or organ failure.

Past work from pharmaceutical companies has focused on finding a vaccine to prevent dengue fever. However, the current dengue vaccines are not widespread and accessible for all and it is currently only recommended for individuals who have previously been infected with dengue to prevent another infection. Recently, researchers from the KU Leuven Rega and the Centre for Drug Design and Discovery (CD3) have developed the first antiviral pill that can treat Dengue Fever. 

The research was reported earlier this month in the journal Nature and details the researcher’s work creating a drug that blocks the ability of the dengue virus to replicate and produce more viral particles. The drug achieves this by inhibiting the interaction of two viral proteins that are responsible for copying and replicating the genetic material of the virus. After creating the drug, the researchers then tested the drug in mice who were experimentally infected with the dengue virus. 

Several important findings came out of the research. First, the researchers found that the drug worked to prevent the replication of the dengue virus in the experimental mice and that this was achieved with even the lowest dose of the drug. Second, in a subset of mice, the researchers allowed the virus to replicate and reach peak levels in the mice. Importantly, when the virus reached peak levels, the drug was then administered, and even when treatment started after viral load was high, the drug resulted in a significant and rapid reduction in virus particles in the blood. Third, the drug was also effective at preventing viral infection. This is an important aspect of the novel drug, as Professor Johan Neyts, a lead author on the study said, “potent and safe dengue drugs that can be easily taken as tablets could offer anyone effective protection for a certain period of time.” The researchers are continuing the research to create a compound that can be tested in humans.  

 

Sources: World Health OrganizationWorld Health OrganizationCDCnature

About the Author
  • Science and medical writer | Researcher | Interested in the intersection between translational science, drug development, and policy
You May Also Like
OCT 21, 2021
Drug Discovery & Development
Cholesterol Drug Regrows Neurons After Spinal Cord Injury
OCT 21, 2021
Cholesterol Drug Regrows Neurons After Spinal Cord Injury
Fenofibrate, an FDA-approved drug used to reduce cholesterol levels, causes sensory neurons in the spine following spina ...
NOV 12, 2021
Cannabis Sciences
Battle of the Cannabinoids: Which Cannabis Compound Could Most Effectively Treat IBD?
NOV 12, 2021
Battle of the Cannabinoids: Which Cannabis Compound Could Most Effectively Treat IBD?
With 3 million people from the U.S. reporting clinical cases in 2015 – accompanied by an increased projected incid ...
NOV 14, 2021
Genetics & Genomics
Cancer Drug Target Could Actually Worsen Disease
NOV 14, 2021
Cancer Drug Target Could Actually Worsen Disease
Cancer drugs have been developed that target an enzyme, Shp2. But that enzyme has a more complex role than we knew.
NOV 18, 2021
Cannabis Sciences
Could Cannabis-Based Compounds Be the Next New Class of Antibiotics?
NOV 18, 2021
Could Cannabis-Based Compounds Be the Next New Class of Antibiotics?
According to the Centers for Disease Prevention and Control (CDC), antibiotic-resistant bacterial or fungal strains infe ...
NOV 24, 2021
Drug Discovery & Development
A prescription digital therapeutic to treat alcohol use disorders
NOV 24, 2021
A prescription digital therapeutic to treat alcohol use disorders
Can a software application be used treat alcohol use disorders? The medical technology company Pear Therapeutics is ...
NOV 30, 2021
Cannabis Sciences
Terpene-Mediated Modulation of Cannabinoid Activity
NOV 30, 2021
Terpene-Mediated Modulation of Cannabinoid Activity
A popular theory – the “entourage effect” – has been gaining traction amongst the cannabis scien ...
Loading Comments...